| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| July 1, 2026 | ±5.3% | +6.7% | under-priced |
| April 2, 2026 | ±5.0% | +1.3% | over-priced |
| January 5, 2026 | ±1.6% | +0.5% | over-priced |
| July 3, 2025 | ±2.0% | +0.1% | over-priced |
| April 4, 2025 | ±2.4% | -4.8% | under-priced |
| January 8, 2025 | ±1.9% | -0.5% | over-priced |
| July 3, 2024 | ±1.9% | +0.2% | over-priced |
| April 3, 2024 | ±1.5% | -0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.50 | $623M | $127M |
| Q2 FY2026 | $3.59 | $611M | $133M |
| Q1 FY2026 | $4.06 | $608M | $153M |
| Q4 FY2025 | $4.02 | $597M | $154M |
Factset Research Systems (FDS) reports in 86 days, with the next report estimated for October 22, 2026. Across the last 8 reports, options priced an average ±2.7% earnings move while the stock actually moved 1.9% on average — the market has systematically over-priced FDS's earnings risk. Fundamentals into the print: EPS down 9.6% year-over-year, revenue up 6.4%. QuantLogix's live 5-factor engine currently reads FDS as a strong buy at 86/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →